Correlation Between Pfizer and ProShares UltraShort

Can any of the company-specific risk be diversified away by investing in both Pfizer and ProShares UltraShort at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ProShares UltraShort into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and ProShares UltraShort SP500, you can compare the effects of market volatilities on Pfizer and ProShares UltraShort and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ProShares UltraShort. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ProShares UltraShort.

Diversification Opportunities for Pfizer and ProShares UltraShort

-0.41

Correlation Coefficient

Pfizer  ProShares UltraShort

Very good diversification

The 3 months correlation between Pfizer and ProShares is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ProShares UltraShort SP500 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares UltraShort and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ProShares UltraShort. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares UltraShort has no effect on the direction of Pfizer i.e., Pfizer and ProShares UltraShort go up and down completely randomly.

Pair Corralation between Pfizer and ProShares UltraShort

Considering the 90-day investment horizon Pfizer Inc is expected to generate 1.13 times more return on investment than ProShares UltraShort. However, Pfizer is 1.13 times more volatile than ProShares UltraShort SP500. It trades about 0.12 of its potential returns per unit of risk. ProShares UltraShort SP500 is currently generating about -0.17 per unit of risk. If you would invest  2,261  in Pfizer Inc on May 17, 2025 and sell it today you would earn a total of  250.00  from holding Pfizer Inc or generate 11.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  ProShares UltraShort SP500

Pfizer Inc

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in September 2025.

ProShares UltraShort

Risk-Adjusted Performance

Weakest

Over the last 90 days ProShares UltraShort SP500 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Etf's fundamental indicators remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the exchange-traded fund private investors.

Pair Trading with Pfizer and ProShares UltraShort

The main advantage of trading using opposite Pfizer and ProShares UltraShort positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ProShares UltraShort can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares UltraShort will offset losses from the drop in ProShares UltraShort's long position.

The idea behind Pfizer Inc and ProShares UltraShort SP500 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.